Informed Prostate Cancer Patient Support

A New View of Life Expectancy | CDC

Full article: Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement tandfonline.com Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement Evelyne Lerut 24–31 minutes Lymph nodes on the draining lymphatic vessels from the primary tumor are often the first place of metastasis, as well as a springboard for further systemic dissemination. It is therefore evident that the presence of lymph node (LN) metastases is an important prognostic factor in many cancers and also in prostate cancer (PCa) [ Citation 1 ]. Until now, only an extended pelvic LN dissection (LND) ensures a reliable LN staging. Yet, this invasive procedure is associated with significant morbidity. Currently, sufficiently accurate non-invasive strategies to pr...

ChatGPT shows limited ability to recommend guidelines-based cancer treatments | ScienceDaily sciencedaily.com ChatGPT shows limited ability to recommend guidelines-based cancer treatments 5–6 minutes For many patients, the internet serves as a powerful tool for self-education on medical topics. With ChatGPT now at patients' fingertips, researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, assessed how consistently the artificial intelligence chatbot provides recommendations for cancer treatment that align with National Comprehensive Cancer Network (NCCN) guidelines. Their findings, published in JAMA Oncology , show that in approximately one-third of cases, ChatGPT 3.5 provided an inappropriate ("non-concordant") recommendation, highlighting the need for awareness of the technology...

The impact of race on survival in metastatic prostate cancer: a systematic literature review | Prostate Cancer and Prostatic Diseases nature.com The impact of race on survival in metastatic prostate cancer: a systematic literature review Arondekar, Bhakti 57–72 minutes Background Prostate cancer is the second most common cancer among men globally, with 1.4 million new cases diagnosed in 2020 [ 1 ]. Patients with metastatic prostate cancer (mPC) have a poor prognosis, with the five-year survival rate reduced from greater than 99% in localized and regional forms of the disease to 32.3% in mPC [ 2 ]. Racial and ethnic minorities are disproportionately affected by mPC, with the greatest age-adjusted incidence rates observed in Black men [ 3 ]. Recent years have seen numerous advancements for patients with prostate cancer, including improvements i...